The Czech government is set to discuss regulated sales of kratom and cannabis with THC levels up to 1% on Wednesday, with the changes potentially taking effect in July.

The regulation focuses on substances deemed to pose low public health and social risks based on current scientific evidence.

These include kratom and kratom extracts, known for their stimulant and pain-relieving effects; cannabis with up to 1 percent THC, a low-potency form of cannabis with minimal psychoactive effects.

Low-THC cannabis products will be permitted to be sold in licensed stores starting this summer in Czechia, although certain forms of commerce such as automated vending machines remain prohibited.

Additionally, starting on April 1, 2025, general practitioners (GPs) in the Czech Republic will be authorized to prescribe medical cannabis to suffering patients. The policy change is a result of a new decree from the nation’s Ministry of Health.

“The decree allows GPs to prescribe medicinal cannabis for chronic, intractable pain,” Ministry spokesperson Ondřej Jakob previously said.

Medical cannabis was first legalized in Czechia in 2013, however, only specialists can currently prescribe it resulting in roughly 8,000 patients receiving legal access.

There is also a push in Czechia for wider adult-use cannabis legalization. However, that effort must clear various political hurdles before reaching the finish line and becoming law.

The Czech Republic’s cabinet approved a plan late last year that would permit adults in the European nation to cultivate multiple plants in their private residences and possess a personal amount of cannabis.

The proposal is part of a draft regulation listing so-called psychomodulatory substances, which falls under this year’s psychomodulants act.

Would you like us to write about your business? Find out more